Lisa Frey

Statistics

Publications

Citations

1.1K

H-Index

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Biopharma Co., Ltd. (Japan)

Nihon Fukushi University

Lisa Frey is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, medicinal chemistry, and synthetic medicinal chemistry.

Publications per year

1993–2021

Publications

Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor

Michael E. Pierce, Rodney L. Parsons, Lilian Radesca et al. · The Journal of Organic Chemistry · 1998 · 215 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

Asymmetric Synthesis of MK-0499

David M. Tschaen, Lee Abramson, Dongwei Cai et al. · The Journal of Organic Chemistry · 1995 · 152 citations

Natural Sciences, Chemistry, Analytical Chemistry +7

Practical Asymmetric Synthesis of an Endothelin Receptor Antagonist

Zhiguo J. Song, Mangzhu Zhao, Richard Desmond et al. · The Journal of Organic Chemistry · 1999 · 96 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

An Investigation into Causes and Effects of High Cyanide Levels in the Palladium-Catalyzed Cyanation Reaction

Karen Marcantonio, Lisa Frey, Yong Liu et al. · Organic Letters · 2004 · 84 citations

Natural Sciences, Chemical Engineering, Chemistry +6

Catalytic, Enantioselective Synthesis of Taranabant, a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

Cheng‐yi Chen, Lisa Frey, Scott Shultz et al. · Organic Process Research & Development · 2007 · 80 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

1–5 of 21